The initial subchondroplasty procedure was performed on (b)(6) 2018.A year later, the patient was presented with avascular necrosis of the talus with the notification date of (b)(6) 2019.A postoperative mri was provided for review.The procedure was reviewed with the site's clinical advisory board, who stated that the target site was a subtalar osteochondral lesion with cystic change and surrounding bml and that the patient was a good candidate for scp.The lesion location corresponds closely to the blood supply from the posterior tibial artery - the only supply to the talar body (the talus, like the navicular, has a famously tenuous blood supply and is prone to avn).The injection was determined to be in the correct spot, and the injected volume appeared to be about 3-5cc was injected.The clinical opinion was that too much accufill was injected into the talus during this procedure, leading to the clinical changes.The volume recommendation in scp surgical technique guide and surgical courses for scp treatment of the talar body is 1 to 1 ½ cc of accufill.This complaint is being closed based on surgical technique.The responsible surgeon has been made aware of these findings.The product was not returned for evaluation, as it remains implanted in the patient.The dhr for the raw material and finished goods lot was reviewed, and no anomalies related to the complaint condition were noted.
|